Literature DB >> 32698003

Enhanced Sensory Coding in Mouse Vibrissal and Visual Cortex through TRPA1.

Ehsan Kheradpezhouh1, Matthew F Tang2, Jason B Mattingley3, Ehsan Arabzadeh4.   

Abstract

Transient receptor potential ankyrin 1 (TRPA1) is a non-selective cation channel, broadly expressed throughout the body. Despite its expression in the mammalian brain, little is known about the contribution of TRPA1 to cortical function. Here, we characterize how TRPA1 affects sensory information processing in two cortical areas in mice: the primary vibrissal (whisker) somatosensory cortex (vS1) and the primary visual cortex (V1). In vS1, local activation of TRPA1 by allyl isothiocyanate (AITC) increases the ongoing activity of neurons and their evoked response to vibrissal stimulation, producing a positive gain modulation. The gain modulation is reversed by TRPA1 inhibitor HC-030031 and is absent in TRPA1 knockout mice. Similarly, in V1, TRPA1 activation increases the gain of direction and orientation selectivity. Linear decoding of V1 population activity confirms faster and more reliable encoding of visual signals under TRPA1 activation. Overall, our findings reveal a physiological role for TRPA1 in enhancing sensory signals in the mammalian cortex.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  TRP Channels; TRPA1; cortex; gain modulation; sensory processing; somatosensory; tuning; vibrissae; visual; whisker

Mesh:

Substances:

Year:  2020        PMID: 32698003     DOI: 10.1016/j.celrep.2020.107935

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  2 in total

1.  A protocol for simultaneous in vivo juxtacellular electrophysiology and local pharmacological manipulation in mouse cortex.

Authors:  Ehsan Kheradpezhouh; Wricha Mishra; Ehsan Arabzadeh
Journal:  STAR Protoc       Date:  2021-02-02

Review 2.  Advances in TRP channel drug discovery: from target validation to clinical studies.

Authors:  Ari-Pekka Koivisto; Maria G Belvisi; Rachelle Gaudet; Arpad Szallasi
Journal:  Nat Rev Drug Discov       Date:  2021-09-15       Impact factor: 112.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.